JP2008520703A5 - - Google Patents

Download PDF

Info

Publication number
JP2008520703A5
JP2008520703A5 JP2007543267A JP2007543267A JP2008520703A5 JP 2008520703 A5 JP2008520703 A5 JP 2008520703A5 JP 2007543267 A JP2007543267 A JP 2007543267A JP 2007543267 A JP2007543267 A JP 2007543267A JP 2008520703 A5 JP2008520703 A5 JP 2008520703A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
formula
hydrogen
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007543267A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008520703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/041817 external-priority patent/WO2006057899A2/en
Publication of JP2008520703A publication Critical patent/JP2008520703A/ja
Publication of JP2008520703A5 publication Critical patent/JP2008520703A5/ja
Ceased legal-status Critical Current

Links

JP2007543267A 2004-11-22 2005-11-18 2α−メチル−19−ノル−(20S)−1α−ヒドロキシ−ビスホモプレグナカルシフェロールおよびその使用 Ceased JP2008520703A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63018404P 2004-11-22 2004-11-22
PCT/US2005/041817 WO2006057899A2 (en) 2004-11-22 2005-11-18 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses

Publications (2)

Publication Number Publication Date
JP2008520703A JP2008520703A (ja) 2008-06-19
JP2008520703A5 true JP2008520703A5 (https=) 2009-01-15

Family

ID=36218156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543267A Ceased JP2008520703A (ja) 2004-11-22 2005-11-18 2α−メチル−19−ノル−(20S)−1α−ヒドロキシ−ビスホモプレグナカルシフェロールおよびその使用

Country Status (8)

Country Link
US (3) US7241751B2 (https=)
EP (1) EP1846369A2 (https=)
JP (1) JP2008520703A (https=)
AU (1) AU2005309804B9 (https=)
CA (1) CA2588399A1 (https=)
MX (1) MX2007006542A (https=)
NZ (1) NZ555283A (https=)
WO (1) WO2006057899A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
JP2008520689A (ja) 2004-11-22 2008-06-19 ウィスコンシン・アルムニ・リサーチ・ファウンデーション 19,26,27−トリノル−(20S)−1α−ヒドロキシビタミンD3の2α−メチルおよび2β−メチル類似体およびそれらの使用
EP1827452B1 (en) * 2004-11-22 2011-03-02 Wisconsin Alumni Research Foundation 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
JP2008520708A (ja) * 2004-11-22 2008-06-19 ウイスコンシン アラムニ リサーチ ファンデーション 2−メチレン−19−ノル−(20R)−1α−ヒドロキシ−ビスホモプレグナカルシフェロール
AU2005309804B9 (en) * 2004-11-22 2011-12-08 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses
ATE467614T1 (de) * 2004-11-22 2010-05-15 Wisconsin Alumni Res Found 2-methylen-19,26,27-trinor-(20s)-1-alpha- hydroxyvitamin d3 and dessen verwendungen
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US8193170B2 (en) 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US7879829B2 (en) * 2008-07-10 2011-02-01 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US8399439B2 (en) 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
EP2525799B1 (en) 2009-10-02 2014-09-03 Wisconsin Alumni Research Foundation (20s,22e)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin d3 analogs
US8217023B2 (en) 2009-10-02 2012-07-10 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
US8664206B2 (en) 2010-03-23 2014-03-04 Wisconsin Alumni Research Foundation Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
AU2011232633B2 (en) * 2010-03-23 2014-05-29 Wisconsin Alumni Research Foundation (20S)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22- dimethyl-1alpha,25-hydroxyvitamin D3
JP5931845B2 (ja) * 2010-03-23 2016-06-08 ウイスコンシン アラムニ リサーチ ファンデーション 2−メチレン−19−ノル−22−メチル−1α,25−ジヒドロキシビタミンD3のジアステレオマー
CN104086019A (zh) * 2014-06-17 2014-10-08 湖北富邦科技股份有限公司 一种工业高浓度含磷废水的处理方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6806262B2 (en) * 2000-05-31 2004-10-19 Wisconsin Alumni Research Foundation 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
WO2002020021A1 (en) * 2000-09-08 2002-03-14 Wisconsin Alumni Research Foundation 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
WO2002094247A2 (en) * 2001-05-22 2002-11-28 Bioxell S.P.A. Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
GB0305332D0 (en) * 2003-03-10 2003-04-09 Leuven K U Res & Dev Biological evaluation of novel vitamin D analogues
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
AU2005309804B9 (en) * 2004-11-22 2011-12-08 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses
JP2008520689A (ja) * 2004-11-22 2008-06-19 ウィスコンシン・アルムニ・リサーチ・ファウンデーション 19,26,27−トリノル−(20S)−1α−ヒドロキシビタミンD3の2α−メチルおよび2β−メチル類似体およびそれらの使用
CA2588412A1 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses

Similar Documents

Publication Publication Date Title
JP2008520703A5 (https=)
JP2008520689A5 (https=)
JP2008520705A5 (https=)
JP2008520691A5 (https=)
JP2005529878A5 (https=)
TW408102B (en) Phenyl urea compounds and their use for the treatment of disease states medicated by the chemokine, Interleukin-8 (IL-8)
JP2010504995A5 (https=)
CN103443085A (zh) 喹唑啉二酮及其应用
JP2006523216A5 (https=)
TW200944540A (en) C20-C21 substituted glucocorticoid receptor agonists
JP2011529032A5 (https=)
JP2006182786A5 (https=)
JP2009515980A5 (https=)
JP2015508092A5 (https=)
JP2008520704A5 (https=)
JP2023088996A (ja) 癌治療
JP2008520716A5 (https=)
CA2588415A1 (en) 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
JP2007504168A5 (https=)
JP2008520709A5 (https=)
JP2008520706A5 (https=)
CA2588410A1 (en) 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
JP2010504994A5 (https=)
JP2005502579A5 (https=)
JP2008520708A5 (https=)